kinray generic & diabetics supply inc.

1 maiden lane, 5th floor
new york, new york 10038

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 21, 2014

NYS DOS ID#
4580431

County
KINGS

Jurisdiction
NEW YORK

Registered Agent
SPIEGEL & UTRERA, P.A., P.C.
1 MAIDEN LANE, 5TH FLOOR
NEW YORK, NEW YORK, 10038

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - KINRAY GENERIC & DIABETICS SUPPLY INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Private Equity-Like Fund Aims to Speed Up Diabetes Research
    By PAUL SULLIVAN - Friday Jul 28, 2017

    The goal of the T1D Fund, which received $32 million in seed funding from the Juvenile Diabetes Research Foundation, is to speed new products to market.

    Source: New York Times
  • Rapper Common surprises students at NY school, donates money
    By MESFIN FEKADU, AP Music Writer - Thursday Jul 20, 2017

    Rapper Common surprises students at NY school, donates moneyNEW YORK (AP) — Oscar and Grammy winner Common surprised a group of New York students by donating $10,000 to help their teachers buy supplies like calculators and science kits.The rapper-actor partnered with the nonprofit AdoptAClassroom.org and Burlington Stores to give Renaissance School of the Arts in Harlem the funds on Thursday.Jadon-Li M. Antoine, an aspiring musician, actor and dancer, said Common's visit motivates him to keep aiming for his dreams.Burlington has been raising money from its 599 stores to help other schools, asking customers to donate $1 or more.

    Source: SFGATE.com: Daily Dish
  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • Eli Lilly Fronts $55M for Rights to KeyBioscience’s Diabetes Drugs
    By Frank Vinluan - Thursday Jun 8, 2017

    With competition threatening to chip away at its diabetes stronghold, Eli Lilly is shoring up its pipeline with a deal that gives the company access to a potential new class of diabetes drugs. Indianapolis-based Lilly (NYSE: LLY) has agreed to pay $55 million up front to KeyBioscience in exchange for rights to compounds in various […]

    Source: Xconomy VC, Deals, & Startups Feed
  • New York Today: New York Today: New Subway Clocks
    By JONATHAN WOLFE - Monday Aug 7, 2017

    Monday: Rolling out new subway clocks, the Corkscrew Theater Festival, and National Lighthouse Day.

    Source: NYT > Home Page
  • Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More
    By Alex Lash - Friday Aug 11, 2017

    With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital. The FDA reported that generic drug approvals are set to hit a record; the agency under Commissioner Scott […]

    Source: Xconomy New York
kinray generic amp diabetics supply inc new york ny